The Absorption Company

We invested in The Absorption Company because supplements are a category where most products don't actually do what they say. Not because of fraud, but because of bioavailability. A nutrient you can't absorb is a nutrient that doesn't count. The team understood that, and built a product line around the part of the equation most operators ignore.

The discipline shows up in the formulation work, the clinical backing, and the refusal to sell what the team couldn't explain in detail. The product line reflects that discipline: tightly curated, specific in its claims, and priced to compete on value rather than on margin.

Most supplement companies we evaluate fall into one of two patterns. They're either legacy operators with strong distribution and formulations that haven't been updated in decades, or they're DTC insurgents with beautiful packaging and product that doesn't hold up to clinical scrutiny. The Absorption Company sits in a narrower third category: clinical discipline, operator credibility, and consumer design sensibility. We came in at Seed because the approach was right, the founders were honest operators, and the category was finally ready to reward real science.

The retention data in the early months already suggested that customers could feel the difference. That's the metric that matters most in supplements, and it's the one almost nobody actually moves.

The Absorption Company builds supplements designed around bioavailability. The rate at which the body actually absorbs and uses what's in the pill. A focus that is obvious in principle and rare in practice.

The product line is anchored in clinical research, formulated for specific absorption outcomes, and priced to compete directly with mass supplements that the team can demonstrate are less effective dose-for-dose. The positioning is quietly uncompromising: the company doesn't market around trends, and it doesn't chase every wellness flavor-of-the-month. It sells products the team is willing to defend on the merits.

Distribution is building methodically through specialty retail and direct channels that let the brand hold margin without being forced into the promotional cycle that erodes trust in the supplement category. Retention is high in the segments where the product has been live longest, which is the leading indicator of a consumer supplement business that will compound.

We remain committed patient capital in this position.